The Oncology Institute, Inc.

The Oncology Institute, Inc.verified

TOI

Price:

$0.154

Market Cap:

$11.64M

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.[Read more]

Industry

Medical - Care Facilities

IPO Date

2020-06-04

Stock Exchange

NASDAQ

Ticker

TOI

The ROE as of November 2024 (TTM) for The Oncology Institute, Inc. (TOI) is -176.71%

According to The Oncology Institute, Inc.’s latest financial reports and current stock price. The company's current ROE is -176.71%. This represents a change of 216.50% compared to the average of -55.83% of the last 4 quarters.

The Oncology Institute, Inc. (TOI) Historical ROE (quarterly & annually)

How has TOI ROE performed in the past?

The mean historical ROE of The Oncology Institute, Inc. over the last ten years is -35.89%. The current -176.71% ROE has changed 392.42% with respect to the historical average. Over the past ten years (40 quarters), TOI's ROE was at its highest in in the June 2020 quarter at 20.36%. The ROE was at its lowest in in the September 2024 quarter at -104.08%.

Quarterly (TTM)
Annual

Average

-35.89%

Median

-10.01%

Minimum

-145.67%

Maximum

1.33%

The Oncology Institute, Inc. (TOI) ROE by Quarter and Year

Discovering the peaks and valleys of The Oncology Institute, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 435.08%

Maximum Annual ROE = 1.33%

Minimum Annual Increase = -Infinity%

Minimum Annual ROE = -145.67%

Quarterly (TTM)
Annual
YearROEChange
2023-145.67%-11060.81%
20221.33%-112.67%
2021-10.49%-79.41%
2020-50.96%435.08%
2019-9.52%-Infinity%

The Oncology Institute, Inc. (TOI) Average ROE

How has TOI ROE performed in the past?

The current ROE of The Oncology Institute, Inc. (TOI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-51.61%

5-year avg

-43.06%

10-year avg

-35.89%

The Oncology Institute, Inc. (TOI) ROE vs. Peers

How is TOI’s ROE compared to its peers?

The Oncology Institute, Inc.’s ROE is less than Ramsay Health Care Limited (18.26%), less than Medical Facilities Corporation (24.59%), less than Jack Nathan Medical Corp. (118.70%), less than MCI Onehealth Technologies Inc. (0%), greater than Fresenius SE & Co. KGaA (-2.01%), greater than Cano Health, Inc. (-3260.92%), greater than LifeStance Health Group, Inc. (-6.66%), greater than agilon health, inc. (-50.48%), less than The Pennant Group, Inc. (13.81%), greater than Brookdale Senior Living Inc. (-59.31%), greater than Surgery Partners, Inc. (-3.11%), less than Select Medical Holdings Corporation (18.46%), less than The Ensign Group, Inc. (14.83%), greater than Pediatrix Medical Group, Inc. (-32.29%), less than Universal Health Services, Inc. (16.10%), less than Addus HomeCare Corporation (8.92%), less than Encompass Health Corporation (23.50%), less than Concord Medical Services Holdings Limited (12.96%), less than American Shared Hospital Services (15.97%), greater than Sonida Senior Living, Inc. (-50.92%), greater than The Joint Corp. (-71.30%),

Build a custom stock screener for The Oncology Institute, Inc. (TOI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like The Oncology Institute, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

The Oncology Institute, Inc. (TOI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like The Oncology Institute, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is The Oncology Institute, Inc.'s ROE?

How is the ROE calculated for The Oncology Institute, Inc. (TOI)?

What is the highest ROE for The Oncology Institute, Inc. (TOI)?

What is the 3-year average ROE for The Oncology Institute, Inc. (TOI)?

What is the 5-year average ROE for The Oncology Institute, Inc. (TOI)?

How does the current ROE for The Oncology Institute, Inc. (TOI) compare to its historical average?